FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Thomas Burke

Research Profile

Geographic Areas

United States

Chemicals & Drugs

Occupations

Disorders

Concepts & Ideas

Organizations

United States Environmental Protection Agency

Co-author Network

Publications

TOP 3
Mythili Aingaran; Thomas A Burke; Ming Dao; Monica Diez-Silva; Sue KaYee Law; Chwee Teck Lim; Evan Meyer; Zhangli Peng; Tobias Spielmann; Subra Suresh; Andreas Undisz; Rou Zhang; Matthias Marti
Host cell deformability is linked to transmission in the human malaria parasite Plasmodium falciparum.
Ramya Chari; Thomas A Burke; Ronald White; MARY FOX
Integrating susceptibility into environmental policy: an analysis of the national ambient air quality standard for lead.
Mary C Sheehan; Patrick N Breysse; Thomas A Burke; John McGready; Ana Navas-Acien; MARY FOX
Association of markers of chronic viral hepatitis and blood mercury levels in US reproductive-age women from NHANES 2001-2008: a cross-sectional study.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Thomas Burke (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Mythili Aingaran; Thomas A Burke; Ming Dao; Monica Diez-Silva; Sue KaYee Law; Chwee Teck Lim; Evan Meyer; Zhangli Peng; Tobias Spielmann; Subra Suresh; Andreas Undisz; Rou Zhang; Matthias Marti
Host cell deformability is linked to transmission in the human malaria parasite Plasmodium falciparum.
Cellular microbiology 2012;14(7):983-93.
2012: Ramya Chari; Thomas A Burke; Ronald White; MARY FOX
Integrating susceptibility into environmental policy: an analysis of the national ambient air quality standard for lead.
International journal of environmental research and public health 2012;9(4):1077-96.
2012: Mary C Sheehan; Patrick N Breysse; Thomas A Burke; John McGready; Ana Navas-Acien; MARY FOX
Association of markers of chronic viral hepatitis and blood mercury levels in US reproductive-age women from NHANES 2001-2008: a cross-sectional study.
Environmental health : a global access science source 2012;11():62.
2011: Joanna Zablotsky Kufel; BETH RESNICK; MARY FOX; Shannon Frattaroli; Andrea Carlson Gielen; Thomas A Burke
Local food protection and safety infrastructure and capacity: a Maryland case study.
Journal of public health management and practice : JPHMP 2011;17(6):534-41.
2011: Joanna S Zablotsky Kufel; MARY FOX; John McGready; BETH RESNICK; James P Yager; Thomas A Burke
The impact of local environmental health capacity on foodborne illness morbidity in Maryland.
American journal of public health 2011;101(8):1495-500.
2011: Kathrin Buchholz; Thomas A Burke; Kim C Williamson; Roger C Wiegand; Dyann F Wirth; Matthias Marti
A high-throughput screen targeting malaria transmission stages opens new avenues for drug development.
The Journal of infectious diseases 2011;203(10):1445-53.
2011: Tracey J Woodruff; Thomas A Burke; Lauren Zeise
The need for better public health decisions on chemicals released into our environment.
Health affairs (Project Hope) 2011;30(5):957-67.
2011: Thomas A Burke; Tami Wisniewski; Frank R Ernst
Resource utilization and costs associated with chemotherapy-induced nausea and vomiting (CINV) following highly or moderately emetogenic chemotherapy administered in the US outpatient hospital setting.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2011;19(1):131-40.
2010: Eileen Abt; Joseph V Rodricks; Jonathan I Levy; Lauren Zeise; Thomas A Burke
Science and decisions: advancing risk assessment.
Risk analysis : an official publication of the Society for Risk Analysis 2010;30(7):1028-36.
2010: MARY FOX; Frank C Curriero; Kathryn Kulbicki; BETH RESNICK; Thomas A Burke
Evaluating the community health legacy of WWI chemical weapons testing.
Journal of community health 2010;35(1):93-103.
2009: BETH RESNICK; Joanna Zablotsky; Thomas A Burke
Protecting and promoting the nation's health: the environmental public health workforce as a critical component.
Journal of public health management and practice : JPHMP 2009;15(6 Suppl):S40-5.
2009: BETH RESNICK; Joanna Zablotsky; Erik R Janus; Bradley Maggy; Thomas A Burke
An examination of environmental public health organizational and workforce configurations in the Northeast/Mid-Atlantic United States: how do we determine if these configurations impact performance?
Journal of public health management and practice : JPHMP 2009;15(6):509-17.
2009: Lori Uscher Pines; Jon S Vernick; Frank C Curriero; Richard Lieberman; Thomas A Burke
Disaster-related injuries in the period of recovery: the effect of prolonged displacement on risk of injury in older adults.
The Journal of trauma 2009;67(4):834-40.
2009: Lainie Rutkow; Mindi B Levin; Thomas A Burke
Meeting local needs while developing public health practice skills: a model community-academic partnership.
Journal of public health management and practice : JPHMP 2009;15(5):425-31.
2009: Ronald White; Ila Cote; Lauren Zeise; MARY FOX; Francesca Dominici; Thomas A Burke; Paul D White; Dale B Hattis; Jonathan M Samet
State-of-the-science workshop report: issues and approaches in low-dose-response extrapolation for environmental health risk assessment.
Environmental health perspectives 2009;117(2):283-7.
2009: Sheenu Chandwani; Chuck Wentworth; Thomas A Burke; Thomas Patterson
Utilization and dosage pattern of echinocandins for treatment of fungal infections in US hospital practice.
Current medical research and opinion 2009;25(2):385-93.
2008: Kristen C Malecki; BETH RESNICK; Thomas A Burke
Effective environmental public health surveillance programs: a framework for identifying and evaluating data resources and indicators.
Journal of public health management and practice : JPHMP 2008;14(6):543-51.
2008: Charles E Rodes; Edo Pellizzari; Michael J Dellarco; Mitchell D Erickson; Daniel A Vallero; Dori B Reissman; Paul J Lioy; Morton Lippmann; Thomas A Burke; Bernard D Goldstein
ISEA2007 panel: integration of better exposure characterizations into disaster preparedness for responders and the public.
Journal of exposure science & environmental epidemiology 2008;18(6):541-50.
2008: RONI NEFF; Frank C Curriero; Thomas A Burke
Just in the wrong place...?: geographic tools for occupational injury/illness surveillance.
American journal of industrial medicine 2008;51(9):680-90.
2008: Hemant Phatak; Chuck Wentworth; Thomas A Burke
Lipid testing among patients beginning statin therapy in general practice in the United Kingdom.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 2008;11(5):933-8.
2008: Sachin J Kamal-Bahl; Thomas A Burke; Douglas J Watson; Charles E Wentworth
Dosage, titration, and gaps in treatment with extended release niacin in clinical practice.
Current medical research and opinion 2008;24(6):1817-21.
2008: Keeve Nachman; Jana N Mihalic; Thomas A Burke; ALLISON GEYH
Comparison of arsenic content in pelletized poultry house waste and biosolids fertilizer.
Chemosphere 2008;71(3):500-6.
2008: BETH RESNICK; Joanna Zablotsky; Keeve Nachman; Thomas A Burke
Examining the front lines of local environmental public health practice: a Maryland case study.
Journal of public health management and practice : JPHMP 2008;14(1):42-50.
2007: Erin Dreyling; Elizabeth J Dederick; Ramya Chari; BETH RESNICK; Kristen Chossek Malecki; Thomas A Burke; RONI NEFF
Tracking health and the environment: a pilot test of environmental public health indicators.
Journal of environmental health 2007;70(5):9-16, 38, 40; quiz 41-2.
2007: Thomas A Burke; Miriam C J M Sturkenboom; Pamela Ohman-Strickland; Chuck Wentworth; George G Rhoads
The effect of antihypertensive drugs and drug combinations on the incidence of new-onset type-2 diabetes mellitus.
Pharmacoepidemiology and drug safety 2007;16(9):979-87.
2007: Eric Van Ganse; Laurent Laforest; Thomas A Burke; Hemant Phatak; Thierry Souchet
Mixed dyslipidemia among patients using lipid-lowering therapy in French general practice: an observational study.
Clinical therapeutics 2007;29(8):1671-81.
2007: BETH RESNICK; Joanna Zablotsky; Olivia Farrow; Rodney Glotfelty; Philip Heard; Susan Kelly; Clifford Mitchell; Frances Phillips; Thomas A Burke
Enhancing the Maryland environmental public health workforce: a collaborative approach.
Journal of environmental health 2007;70(1):32-6, 63.
2007: P Barry Ryan; Thomas A Burke; Elaine A Cohen Hubal; Jerome J Cura; Thomas E McKone
Using biomarkers to inform cumulative risk assessment.
Environmental health perspectives 2007;115(5):833-40.
2007: Nadia Shalauta Juzych; BETH RESNICK; Robin Streeter; Julie B Herbstman; Joanna Zablotsky; MARY FOX; Thomas A Burke
Adequacy of state capacity to address noncommunicable disease clusters in the era of environmental public health tracking.
American journal of public health 2007;97 Suppl 1():S163-9.
2007: Jill S Litt; Andrea Wismann; BETH RESNICK; Rebecca Smullin Dawson; Mary Hano; Thomas A Burke
Advancing health and environmental disease tracking: a 5-year follow-up study.
American journal of public health 2007;97(3):456-63.
2007: Sachin J Kamal-Bahl; Thomas A Burke; Douglas Watson; Chuck Wentworth
Discontinuation of lipid modifying drugs among commercially insured United States patients in recent clinical practice.
The American journal of cardiology 2007;99(4):530-4.
2007: Lori Uscher Pines; Sylvia H Bookbinder; Suzanne Miro; Thomas A Burke
From bioterrorism exercise to real-life public health crisis: lessons for emergency hotline operations.
Journal of public health management and practice : JPHMP 2007;13(1):16-22.
2006: Aura Erazo Valle; Tami Wisniewski; Jasmin Isabel Figueroa Vadillo; Thomas A Burke; Roberto Martinez Corona
Incidence of chemotherapy-induced nausea and vomiting in Mexico: healthcare provider predictions versus observed.
Current medical research and opinion 2006;22(12):2403-10.
2006: Thomas A Burke; Ramani N Venketasubramanian
The epidemiology of stroke in the East Asian region: a literature-based review.
International journal of stroke : official journal of the International Stroke Society 2006;1(4):208-15.
2006: Lori Uscher Pines; Saad Omer; Daniel J Barnett; Thomas A Burke; Ran D Balicer
Priority setting for pandemic influenza: an analysis of national preparedness plans.
PLoS medicine 2006;3(10):e436.
2006: Jürgen Angerer; Michael G Bird; Thomas A Burke; Nancy G Doerrer; Larry Needham; Steven H Robison; Linda Sheldon; Harold Zenick
Strategic biomonitoring initiatives: moving the science forward.
Toxicological sciences : an official journal of the Society of Toxicology 2006;93(1):3-10.
2006: Thomas A Burke; Miriam C J M Sturkenboom; Shou-En Lu; Chuck Wentworth; Yong Lin; George G Rhoads
Discontinuation of antihypertensive drugs among newly diagnosed hypertensive patients in UK general practice.
Journal of hypertension 2006;24(6):1193-200.
2006: Ana Navas-Acien; Ellen K Silbergeld; Robin A Streeter; Jeanne M Clark; Thomas A Burke; Eliseo Guallar
Arsenic exposure and type 2 diabetes: a systematic review of the experimental and epidemiological evidence.
Environmental health perspectives 2006;114(5):641-8.
2006: G McInnes; Thomas A Burke; George W Carides
Cost-effectiveness of losartan-based therapy in patients with hypertension and left ventricular hypertrophy: a UK-based economic evaluation of the Losartan Intervention for Endpoint reduction in hypertension (LIFE) study.
Journal of human hypertension 2006;20(1):51-8.
2005: Ana Navas-Acien; ALBERT SHARRETT; Ellen K Silbergeld; Brian S Schwartz; Keeve Nachman; Thomas A Burke; Eliseo Guallar
Arsenic exposure and cardiovascular disease: a systematic review of the epidemiologic evidence.
American journal of epidemiology 2005;162(11):1037-49.
2005: Wong Kok Seng; Shang-Jyh Hwang; Dong Cheol Han; Chua Chin Teong; Juliana Chan; Thomas A Burke; George W Carides; Yon Jong Choi
Losartan reduces the costs of diabetic end-stage renal disease: an Asian perspective.
Nephrology (Carlton, Vic.) 2005;10(5):520-4.
2005: Bengt Jönsson; George W Carides; Thomas A Burke; Erik J Dasbach; Lars H Lindholm; Björn Dahlöf
Cost effectiveness of losartan in patients with hypertension and LVH: an economic evaluation for Sweden of the LIFE trial.
Journal of hypertension 2005;23(7):1425-31.
2005: Armando Arredondo; Thomas A Burke; George W Carides; Edith Lemus; Julio Querol
The impact of losartan on the lifetime incidence of ESRD and costs in Mexico.
Revista de investigación clínica; organo del Hospital de Enfermedades de la Nutrición 2005;57(3):399-405.
2004: MARY FOX; Nga L Tran; John Groopman; Thomas A Burke
Toxicological resources for cumulative risk: an example with hazardous air pollutants.
Regulatory toxicology and pharmacology : RTP 2004;40(3):305-11.
2004: Teofila Vicente-Herrero; Thomas A Burke; Miguel J A Laínez
The impact of a worksite migraine intervention program on work productivity, productivity costs, and non-workplace impairment among Spanish postal service employees from an employer perspective.
Current medical research and opinion 2004;20(11):1805-14.
2004: Jill Litt; Nga Tran; Kristen Chossek Malecki; RONI NEFF; BETH RESNICK; Thomas A Burke
Identifying priority health conditions, environmental data, and infrastructure needs: a synopsis of the Pew Environmental Health tracking project.
Environmental health perspectives 2004;112(14):1414-8.
2004: Aud Nome Dueland; Rogelio Leira; Thomas A Burke; Elizabeth V Hillyer; Susan Bolge
The impact of migraine on work, family, and leisure among young women -- a multinational study.
Current medical research and opinion 2004;20(10):1595-604.
2004: Steve V Morant; D Pettitt; Thomas M MacDonald; Thomas A Burke; Jay L Goldstein
Application of a propensity score to adjust for channelling bias with NSAIDs.
Pharmacoepidemiology and drug safety 2004;13(6):345-53.
2004: Björn Dahlöf; Thomas A Burke; K Krobot; George W Carides; Jonathan Edelman; Richard B Devereux; H-C Diener
Population impact of losartan use on stroke in the European Union (EU): projections from the Losartan Intervention For Endpoint reduction in hypertension (LIFE) study.
Journal of human hypertension 2004;18(6):367-73.
2004: Sean Z Zhao; Chuck Wentworth; Thomas A Burke; Robert W Makuch
Drug switching patterns among patients with rheumatoid arthritis and osteoarthritis using COX-2 specific inhibitors and non-specific NSAIDs.
Pharmacoepidemiology and drug safety 2004;13(5):277-87.
2004: Devon C Payne-Sturges; Thomas A Burke; Patrick N Breysse; Marie Diener-West; Timothy J Buckley
Personal exposure meets risk assessment: a comparison of measured and modeled exposures and risks in an urban community.
Environmental health perspectives 2004;112(5):589-98.
2004: Nga L Tran; Leila M Barraj; Kim Smith; Annabelle Javier; Thomas A Burke
Combining food frequency and survey data to quantify long-term dietary exposure: a methyl mercury case study.
Risk analysis : an official publication of the Society for Risk Analysis 2004;24(1):19-30.
2004: Frederick Wolfe; Kaleb Michaud; Thomas A Burke; Sean Z Zhao
Longer use of COX-2-specific inhibitors compared to nonspecific nonsteroidal antiinflammatory drugs: a longitudinal study of 3639 patients in community practice.
The Journal of rheumatology 2004;31(2):355-8.
2004: Alan H Stern; Joseph L Jacobson; Louise Ryan; Thomas A Burke
Do recent data from the Seychelles Islands alter the conclusions of the NRC Report on the toxicological effects of methylmercury?
Environmental health : a global access science source 2004;3(1):2.
2003: Jay L Goldstein; Sean Z Zhao; Thomas A Burke; Ryan Palmer; Heather von Allmen; Scott C Henderson
Incidence of outpatient physician claims for upper gastrointestinal symptoms among new users of celecoxib, ibuprofen, and naproxen in an insured population in the United States.
The American journal of gastroenterology 2003;98(12):2627-34.
2003: Miriam C J M Sturkenboom; Thomas A Burke; M J D Tangelder; Jeanne P Dieleman; Surrey M Walton; Jay L Goldstein
Adherence to proton pump inhibitors or H2-receptor antagonists during the use of non-steroidal anti-inflammatory drugs.
Alimentary pharmacology & therapeutics 2003;18(11-12):1137-47.
2003: Miriam C J M Sturkenboom; Thomas A Burke; Jeanne P Dieleman; M J D Tangelder; F Lee; Jay L Goldstein
Underutilization of preventive strategies in patients receiving NSAIDs.
Rheumatology (Oxford, England) 2003;42 Suppl 3():iii23-31.
2003: Russell V Becker; Thomas A Burke; Mark A McCoy; Jeffrey P Trotter
A model analysis of costs of blood pressure destabilization and edema associated with rofecoxib and celecoxib among older patients with osteoarthritis and hypertension in a Medicare Choice population.
Clinical therapeutics 2003;25(2):647-62.
2002: Jill S Litt; Thomas A Burke
Uncovering the historic environmental hazards of urban brownfields.
Journal of urban health : bulletin of the New York Academy of Medicine 2002;79(4):464-81.
2002: Sean Z Zhao; Thomas A Burke; Andrew Whelton; Heather von Allmen; Scott C Henderson
Cost of heart failure among hypertensive users of nonspecific NSAIDs and COX-2-specific inhibitors.
The American journal of managed care 2002;8(15 Suppl):S414-27.
2002: Sean Z Zhao; Thomas A Burke; Andrew Whelton; Heather von Allmen; Scott C Henderson
Blood pressure destabilization and related healthcare utilization among hypertensive patients using nonspecific NSAIDs and COX-2-specific inhibitors.
The American journal of managed care 2002;8(15 Suppl):S401-13.
2002: Sean Z Zhao; Thomas A Burke; Andrew Whelton; Heather von Allmen; Scott C Henderson
Comparison of the baseline cardiovascular risk profile among hypertensive patients prescribed COX-2-specific inhibitors or nonspecific NSAIDs: data from real-life practice.
The American journal of managed care 2002;8(15 Suppl):S392-400.
2002: Jane T Osterhaus; Thomas A Burke; Corey May; Chuck Wentworth; Andrew Whelton; Susan Bristol
Physician-reported management of edema and destabilized blood pressure in cyclooxygenase-2-specific inhibitor users with osteoarthritis and treated hypertension.
Clinical therapeutics 2002;24(6):969-89.
2002: Frederick Wolfe; Nancy Flowers; Thomas A Burke; Lester M Arguelles; Dan Pettitt
Increase in lifetime adverse drug reactions, service utilization, and disease severity among patients who will start COX-2 specific inhibitors: quantitative assessment of channeling bias and confounding by indication in 6689 patients with rheumatoid arthritis and osteoarthritis.
The Journal of rheumatology 2002;29(5):1015-22.
2002: Jill S Litt; Nga L Tran; Thomas A Burke
Examining urban brownfields through the public health "macroscope".
Environmental health perspectives 2002;110 Suppl 2():183-93.
2002: Jay L Goldstein; Glenn Eisen; Thomas A Burke; B M Peña; James B Lefkowith; G Steven Geis
Dyspepsia tolerability from the patients' perspective: a comparison of celecoxib with diclofenac.
Alimentary pharmacology & therapeutics 2002;16(4):819-27.
2002: Frederick Wolfe; Janice Anderson; Thomas A Burke; Lester M Arguelles; Dan Pettitt
Gastroprotective therapy and risk of gastrointestinal ulcers: risk reduction by COX-2 therapy.
The Journal of rheumatology 2002;29(3):467-73.
2002: Debra Lerner; John I Reed; Elena Massarotti; Lisa M Wester; Thomas A Burke
The Work Limitations Questionnaire's validity and reliability among patients with osteoarthritis.
Journal of clinical epidemiology 2002;55(2):197-208.
2002: Frank McKenna; L Arguelles; Thomas A Burke; James B Lefkowith; G Steven Geis
Upper gastrointestinal tolerability of celecoxib compared with diclofenac in the treatment of osteoarthritis and rheumatoid arthritis.
Clinical and experimental rheumatology 2002;20(1):35-43.
2002: Linda Rabeneck; Kimberly Wristers; Jay L Goldstein; Glenn Eisen; Seema D Dedhiya; Thomas A Burke
Reliability, validity, and responsiveness of severity of dyspepsia assessment (SODA) in a randomized clinical trial of a COX-2-specific inhibitor and traditional NSAID therapy.
The American journal of gastroenterology 2002;97(1):32-9.
2001: Jonathan M Samet; Thomas A Burke
Turning science into junk: the tobacco industry and passive smoking.
American journal of public health 2001;91(11):1742-4.
2001: Jonathan M Samet; Thomas A Burke
The Bush administration, the environment and public health-warnings from the first 100 days.
International journal of epidemiology 2001;30(4):658-60.
2001: RA Zabinski; Thomas A Burke; J Johnson; Frédéric Lavoie; C Fitzsimon; R Tretiak; JV Chancellor
An economic model for determining the costs and consequences of using various treatment alternatives for the management of arthritis in Canada.
PharmacoEconomics 2001;19 Suppl 1():49-58.
2001: Thomas A Burke; RA Zabinski; D Pettitt; N Maniadakis; Clement Maurath; Jay L Goldstein
A framework for evaluating the clinical consequences of initial therapy with NSAIDs, NSAIDs plus gastroprotective agents, or celecoxib in the treatment of arthritis.
PharmacoEconomics 2001;19 Suppl 1():33-47.
2000: D Pettitt; Jay L Goldstein; A McGuire; J S Schwartz; Thomas A Burke; N Maniadakis
Overview of the arthritis Cost Consequence Evaluation System (ACCES): a pharmacoeconomic model for celecoxib.
Rheumatology (Oxford, England) 2000;39 Suppl 2():33-42; discussion 57-9.
2000: WG Bensen; Sean Z Zhao; Thomas A Burke; RA Zabinski; Robert W Makuch; Clement Maurath; Naurang M Agrawal; G Steven Geis
Upper gastrointestinal tolerability of celecoxib, a COX-2 specific inhibitor, compared to naproxen and placebo.
The Journal of rheumatology 2000;27(8):1876-83.
2000: Nga L Tran; PAUL LOCKE; Thomas A Burke
Chemical and radiation environmental risk management: differences, commonalities, and challenges.
Risk analysis : an official publication of the Society for Risk Analysis 2000;20(2):163-72.
2000: Thomas A Burke; Jill S Litt; MARY FOX
Linking public health and the health of the Chesapeake Bay.
Environmental research 2000;82(2):143-9.
1999: N M Shalauta; Thomas A Burke; L J Gordon; B S Stern; Nga L Tran
An examination of the educational needs for environmental health and protection.
Journal of public health management and practice : JPHMP 1999;5(6):1-12.
1997: Thomas A Burke; N M Shalauta; Nga L Tran; B S Stern
The environmental Web: a national profile of the state infrastructure for environmental health and protection.
Journal of public health management and practice : JPHMP 1997;3(2):1-12.
1995: Thomas A Burke; K Sexton
Integrating science and policy in a National Human Exposure Assessment Survey.
Journal of exposure analysis and environmental epidemiology 1995;5(3):283-96.
1992: Thomas A Burke; H Anderson; N Beach; S Colome; R T Drew; M Firestone; F S Hauchman; T O Miller; D K Wagener; L Zeise
Role of exposure databases in risk management.
Archives of environmental health 1992;47(6):421-9.
1992: Thomas A Burke
Understanding environmental risk: the role of the laboratory in epidemiology, evaluation, and policy setting.
Clinical chemistry 1992;38(8B Pt 2):1519-22.
1992: Thomas A Burke; G Akland
Use of gasoline exposure data and assessment. A summary report of work group III.
Journal of exposure analysis and environmental epidemiology 1992;2(1):147-50.
1991: MICHEL IBRAHIM; G G Bond; Thomas A Burke; P Cole; F N Dost; P E Enterline; M Gough; Raymond S Greenberg; W E Halperin; E McConnell
Weight of the evidence on the human carcinogenicity of 2,4-D.
Environmental health perspectives 1991;96():213-22.
1991: Thomas A Burke; J Fagliano; M Goldoft; R E Hazen; R Iglewicz; T McKee
Chromite ore processing residue in Hudson County, New Jersey.
Environmental health perspectives 1991;92():131-7.
1990: J Fagliano; M Berry; F Bove; Thomas A Burke
Drinking water contamination and the incidence of leukemia: an ecologic study.
American journal of public health 1990;80(10):1209-12.